Vincent J Burgess
CIK 1365408 · Chief Executive Officer · last filed 2025-05-30
Vincent J Burgess is a Chief Executive Officer who has filed 30 SEC Form 4 insider transactions across 3 companies since 2007. The most recent filing, for TELA, was dated May 30, 2025. Across all open-market trades the lifetime net is −$2.2M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $22.9K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
VOLC price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
CARLSBAD, CA 92008
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| TELA | Director | 23,330 | $0.98 | $22.9K | $0 | 7 | 2025-05-30 |
| Acutus Medical, Inc. (AFIB) Delisted | Chief Executive Officer | 61,469 | $0.09 | $5.5K | $0 | 4 | 2022-04-05 |
| Volcano Corp (VOLC) Delisted | VPof Bus.Development&Marketing | 132,850 | — | — | -$2.16M | 19 | 2010-03-02 |
Recent Filings
30 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-05-30 | TELA | Grant (A) | +7,950 | $0 | EDGAR |
| 2024-06-06 | TELA | Grant (A) | +4,250 | $0 | EDGAR |
| 2023-06-02 | TELA | Grant (A) | +3,135 | $0 | EDGAR |
| 2023-03-31 | TELA | Exer (M) | +4,860 | $21.6K | EDGAR |
| 2022-06-02 | TELA | Grant (A) | +3,135 | $0 | EDGAR |
| 2022-04-05 | Acutus Medical, Inc. (AFIB) Delisted | Tax (F) | −3,896 | -$5.1K | EDGAR |
| 2021-08-27 | Acutus Medical, Inc. (AFIB) Delisted | Tax (F) | −1,922 | -$29.8K | EDGAR |
| 2021-06-04 | TELA | Grant (A) | — | $0 | EDGAR |
| 2021-04-02 | Acutus Medical, Inc. (AFIB) Delisted | Grant (A) | +45,065 | $0 | EDGAR |
| 2020-08-07 | Acutus Medical, Inc. (AFIB) Delisted | Grant (A) | +22,222 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.